SCHEMBL4062373

SCHEMBL4062373

NC(=O)N1C=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL670611 0.86
SCHEMBL1380254 0.79
SCHEMBL1101400 0.77
SCHEMBL8053410 0.75
SCHEMBL310712 0.75
SCHEMBL7831444 0.75
Hydrochloric Acid SCHEMBL29471655 0.75
SCHEMBL8801365 0.73
SCHEMBL16621831 0.70
SCHEMBL22536958 0.70 RIPK1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304403-B2 Heterocyclic CETP inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-06 US claimed
EP-1515724-B1 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2009-10-21 EP claimed
EP-0194525-B1 N-CARBAMOYL-AZOLES AND FUNGICIDES CONTAINING THEM BASF Aktiengesellschaft (DE) 1988-08-10 EP claimed
US-4167624-A 5-Hydroxy-PGI1 pyrrolinylamides THE UPJOHN COMPANY (US) 1979-09-11 US claimed
US-4138549-A Inter-phenylene-PG pyrrolinylamides THE UPJOHN COMPANY (US) 1979-02-06 US claimed
US-4129725-A 9-Deoxy-9-methylene-PGF1 -pyrrolinylamides THE UPJOHN COMPANY (US) 1978-12-12 US claimed
CN-112142731-B 2, 4-disubstituted pyrimidine derivative and preparation method and application thereof 成都赜灵生物医药科技有限公司 2022-07-22 CN disclosed
CN-114671920-A Amide penta-acetyl geniposide derivative and preparation method and application thereof 山东省农业科学院 2022-06-28 CN disclosed
US-20210198218-A1 COMPOUNDS FOR THERAPEUTIC USE DART NEUROSCIENCE LLC (US) 2021-07-01 US disclosed
EP-3507277-B1 HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF DISORDERS DART NEUROSCIENCE LLC (US) 2020-11-18 EP disclosed
EP-3507277-A1 HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS Dart NeuroScience LLC (US) 2019-07-10 EP disclosed
WO-2018044896-A1 HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS DART NEUROSCIENCE, LLC (US) 2018-03-08 WO disclosed
US-9676686-B2 Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device JNC CORPORATION (JP) 2017-06-13 US disclosed
US-4118584-A 9-Deoxy-9-methylene-16-phenyl-PGF compounds THE UPJOHN COMPANY (US) 1978-10-03 US disclosed
US-4112224-A PROSTAGLANDIN THE UPJOHN COMPANY (US) 1978-09-05 US disclosed
US-4110532-A PROSTAGLANDINS, SMOOTH MUSCLE STIMULANTS THE UPJOHN COMPANY (US) 1978-08-29 US disclosed
US-4109082-A PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS THE UPJOHN COMPANY (US) 1978-08-22 US disclosed
US-4100192-A Inter-phenylene-PG amides THE UPJOHN COMPANY (US) 1978-07-11 US disclosed
US-4098805-A 9-DEOXY-9-METHYLENE-PGF-TYPE AMIDES THE UPJOHN COMPANY (US) 1978-07-04 US disclosed
US-4097489-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-06-27 US disclosed